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Development of an experimental 
method of systematically 
estimating protein expression 
limits in HEK293 cells
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protein overexpression sometimes causes cellular defects, although the underlying mechanism is 
still unknown. A protein’s expression limit, which triggers cellular defects, is a useful indication of 
the underlying mechanism. in this study, we developed an experimental method of estimating the 
expression limits of target proteins in the human embryonic kidney cell line HEK293 by measuring the 
proteins’ expression levels in cells that survived after the high-copy introduction of plasmid DnA by 
which the proteins were expressed under a strong cytomegalovirus promoter. the expression limits of 
nonfluorescent target proteins were indirectly estimated by measuring the levels of green fluorescent 
protein (GFP) connected to the target proteins with the self-cleaving sequence P2A. The expression limit 
of a model GFP was ~5.0% of the total protein, and sustained GFP overexpression caused cell death. The 
expression limits of Gfps with mitochondria-targeting signals and endoplasmic reticulum localization 
signals were 1.6% and 0.38%, respectively. The expression limits of four proteins involved in vesicular 
trafficking were far lower compared to a red fluorescent protein. The protein expression limit estimation 
method developed will be valuable for defining toxic proteins and consequences of protein overexpression.
Protein overexpression sometimes causes cellular defects1,2. Although the underlying mechanism causing these 
defects is still unknown, it can be estimated using the protein expression limit, which triggers cellular defects3,4. 
For example, a protein with the highest expression limit is considered harmless, and its ultimate overexpression 
causes overloading of protein synthesis5,6. Transported proteins should have lower expression limits than cyto-
plasmic proteins because the overexpression of transported proteins overloads resources for protein transport5,7.
We previously developed an experimental genetic tug-of-war (gTOW) method of estimating the expression 
limits of target proteins in yeasts8–10. The expression limits obtained were useful for classifying the mechanisms 
underlying cellular defects triggered by protein overexpression4,11. In this study, we developed an experimental 
method of systematically evaluating the expression limits of target proteins in the human embryonic kidney cell 
line HEK293 by measuring the target protein level in cells surviving after high-efficient, multicopy introduction 
of plasmid DNA by which the target protein is highly expressed under a cytomegalovirus promoter (CMV-pro).
For proof-of-concept, we estimated the expression limits of a green fluorescent protein (GFP) and its deriv-
atives as model proteins. We also indirectly estimated the expression limits of nonfluorescent target proteins by 
measuring the levels of GFP connected to the target proteins with the self-cleaving sequence P2A by measuring 
GFP fluorescence. Estimation of expression limits slightly but significantly improved by concentrating cells with 
higher expression levels of the target protein using the antagonism between dihydrofolate reductase (DHFR) and 
its inhibitor methotrexate (MTX).
Results
Estimation of GFP expression limit with high-efficient transfection. To develop an experimental 
method of measuring a target protein’s expression limit, we used a GFP as a target protein because its expression 
level is easily estimated by fluorescence of the cells expressing it. We used moxGFP, which folds quickly and does 
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not misfold in the endoplasmic reticulum (ER)12. GFP is considered a nonharmful protein13–15, and its expres-
sion limit in yeast is ~15% of the total protein, which is highest among other proteins in yeast5,7. Therefore, if an 
experimental condition is established that can estimate the expression limit of GFP, it should be applicable to the 
majority of other proteins with lower expression limits compared to GFP.
Figure 1A shows the experimental procedure. The basic principle of this analysis is that we can assume that 
transfection creates a cell population harboring diverse plasmid copy numbers, leading to diverse expression 
levels of a target protein encoded on the plasmid, because the process is random. If the transfection efficiency is 
high enough, the transfected cell population should contain cells close to or exceeding the target protein’s expres-
sion limit. As the growth of cells exceeding the target protein’s expression limit is inhibited, those cells should 
be eliminated from the population. Therefore, the target protein’s expression limit should be observed as the 
highest boundary in the fluorescence of the cell population surviving after a certain period of transfection. We 
used HEK293 cells16,17 because their transfection efficiency using a transfection reagent polyethyleneimine (PEI) 
“Max” is high enough for our purpose18. We used CMV-pro because it is widely recognized as a strong promoter 
in cultured cell lines19,20. The basic structure of the plasmid pTOW-CMV-pro we used in this study is shown in 
Fig. 1B.
We optimized the amount of plasmid DNA for transfection and the analysis timing post-transfection. The 
percentage of cells with higher GFP fluorescence increased with increasing amounts of DNA used for transfec-
tion (Fig. 1C). The percentage and highest boundary did not change with >5 µg DNA (Fig. 1D). The transfection 
efficiency (ratio of GFP-positive cells to the total cell count of 20,000) also increased with increasing amounts 
of DNA but was saturated after 6 µg DNA (Fig. 1E). Therefore, with >5 µg DNA, a sufficient amount of plasmid 
DNA was introduced into cells to provide the expression limit of GFP. The GFP fluorescence of cells reached 
the maximum value after 18 h of transfection and was maintained thereafter (Fig. 1F). Therefore, we fixed the 
experimental conditions as follows: 6 µg of DNA used for transfection and analysis of cells 24 h post-transfection.
Cells expressing a high level of GFP became spherical shaped and detached from the bottom of the culture 
dish (Fig. 1H,I), and these cells died after 72 h (data not shown). These cells were hardly observed in the empty 
vector transfection (Fig. 1G). Therefore, GFP overexpression (i.e., more than its expression limit) causes cell 
death.
Localization to mitochondria and the eR decreases the Gfp expression limit. Previous studies 
have reported that adding localization signals to GFP decreases its expression limit in yeast, probably because of 
overloading of localization7. In this study, we investigated whether localization also decreases the expression limit 
of GFP in HEK293 cells. We attached a mitochondrial targeting signal at the N-terminal construct mitochondrial 
targeting sequence–GFP (MTS-GFP), an ER localization signal at the N-terminal of GFP, and the ER retention 
signal KDEL at the C-terminal of GFP to construct ER-GFP (Fig. 2A).
Cells transfected with the plasmids harboring MTS-GFP or ER-GFP showed lower maximum GFP fluores-
cence compared to cells transfected by plasmids harboring GFP (Fig. 2B,C). The fluorescence intensity means 
were higher in the order of GFP > MTS-GFP > ER-GFP (Fig. 2D). The GFP expressed was observed as a visible 
band when fluorescently labeled whole cellular proteins were separated by sodium dodecyl sulfate–polyacryla-
mide gel electrophoresis (SDS-PAGE) (Fig. 2E, red arrow). The GFP expression level estimated from the band 
intensity was ~4.95% (standard deviation [SD] = 0.78) of the total protein, while MTS-GFP and ER-GFP expres-
sion levels estimated from the band intensity of western blotting with an anti-GFP antibody were 32% and 7.6% 
of the GFP expression level and therefore 1.58% and 0.38% of the total protein, respectively (Fig. 2F,G). In the 
western blotting of MTS-GFP, we observed a band corresponding to the MTS-GFP precursor (Fig. 2F), indicat-
ing that the MTS-GFP expression level in this study actually exceeded the limit of the mitochondrial transport 
process. GFP localization to mitochondria and the ER therefore decreased expression limits in HEK293 cells, as 
observed in yeast.
Estimation of expression limits of nonfluorescent proteins using P2A-GFP. Virus-derived 
P2A peptide induces protein cleavage during translation21–23. Cleaved proteins should be synthesized at the 
same molecular numbers, because they are translated by the same ribosome. Therefore, by placing GFP at the 
C-terminal of P2A peptide, the expression level of the target protein placed at the N-terminal of P2A peptide can 
be indirectly estimated from the GFP expression level. To confirm whether P2A-GFP can be used to estimate the 
expression level of the N-terminal target protein, we analyzed the expression limit of the red fluorescent protein 
(RFP) mCherry using the P2A-GFP fusion protein (Fig. 3A). Microscopic observation of transfected cells showed 
highly correlated RFP and GFP fluorescence (Fig. 3B,C). This high correlation was not due to noncleaved prod-
ucts, because none were observed by western blotting (Fig. 3D,E). These results confirmed that the expression 
level of the target protein placed at the N-terminal of P2A-GFP can be estimated from the GFP expression level. 
Fusing proteins with the noncleaving P2A mutant (P2A*) marginally but significantly decreased GFP expression 
(Fig. 3F; p = 0.04, Student’s t-test). From the western blotting in Fig. 3E, we could interpret that the GFP fluo-
rescence in RFP-P2A-GFP was all from the cleaved GFP, and that in RFP-P2A*-GFP was from the cleaved and 
noncleaved GFPs. This indicates that compared to the expression of fusion proteins, cleaved protein expression 
less perturbs the expression system.
Next, we estimated the expression limits of secreted alkaline phosphatase (SEAP) and human serum albumin 
(HSA) as nonfluorescent target proteins (Fig. 4A). GFP fluorescence of cells transfected with SEAP and HSA 
plasmids was 54% and 5% of GFP fluorescence of cells transfected with the RFP plasmid (Fig. 4B,C). Fluorescence 
decrease seemed not to change in the localization of GFP located at the C-terminal of the secreted proteins, 
because GFP expressed with these plasmids was observed in the entire cytoplasm but not in the secretion machin-
ery (Fig. 4D). This observation is consistent with the finding that P2A peptide effectively separates the localization 
of connected proteins23. Therefore, C-terminal GFP can be used as a cytoplasmic indicator for the production of 
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Figure 1. Experimental conditions to estimate GFP expression limit in HEK293 cells. (A) Experimental 
procedure. HEK293 cells are transfected with a plasmid for GFP expression with a high-efficient transfection. 
After 24 h of transfection, surviving cells are analyzed by flow cytometry. If the promoter strength and transfection 
efficiency are high enough, the GFP expression levels in the transfected cells will reach the expression limit, which 
is observed as the maximum boundary of GFP fluorescence in flow cytometry (shown as a virtual histogram). (B) 
Basic structure of plasmids used in this study. For transient transfection, the plasmid does not have any replication 
origin in cultured cells. The plasmid contains URA3 and 2µORI for recombination-based plasmid construction 
in the budding yeast Saccharomyces cerevisiae beside AmpR and pBR322ORI for selection and amplification in 
Escherichia coli. These factors do not have any specific function in cultured cells. The target gene (here GFP) is 
expressed under the control of CMV-pro. (C,D) Effect of DNA amount on GFP expression level in transfected cells. 
The GFP intensity (AU) of the cell population after 24 h of transfection was analyzed using flow cytometry. DNA 
amounts used in the transfection are shown. (E) Effect of DNA amount on transfection efficiency. The transfection 
efficiency was calculated as the ratio of GFP-positive cells to the total cell count (20,000) from the histogram shown 
in (C,D). The means and SD (error bar) are shown. (F) Time course of GFP expression in transfected cells. The cells 
were analyzed using flow cytometry every hour after transfection with 6 µg of DNA. The GFP fluorescence intensity 
means of the cell population are shown. (G–I) Microscopic image of cells transfected with the empty vector 
(pTOW-CMV-pro, G) and the GFP expression plasmid (pTOW-CMV-pro-GFP, H,I). BF and GFP indicate the 
phase contrast bright field and GFP fluorescence, respectively. Cells were observed using a 20-fold objective lens. 
The flow cytometry histograms were created using the FlowJo software (https://www.flowjo.com/) ver. 8.8.7.
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N-terminal target proteins localized to other cellular compartments. These results indicated that the expression 
limits of these proteins are lower compared to RFP, while the expression limit of HSA is only 10% of that of SEAP.
To test whether SEAP’s expression limit is restricted by transport, we added P2A-GFP to SEAPΔSS in which 
the signal sequence was deleted from SEAP, and estimated the expression limit (SEAPΔSS; Fig. 4A). GFP fluores-
cence of cells transfected with SEAPΔSS showed a significant increase compared to cells transfected with SEAP 
(Fig. 4E,F; p = 0.001, Student’s t-test). This result further confirmed the idea that protein localization decreases 
the protein expression limit.
estimation of expression limits of proteins involved in vesicular transport. Proteins involved 
in vesicular transport, such as Sec24, Sec31, Arf1, and Arf2, are toxic when overexpressed in yeast11. To test 
whether overexpression of their human homologs (i.e., Sec24, Sec31, Rab1, and Rab5) is also toxic, we estimated 
their expression levels using the P2A experimental method (Fig. 5A). GFP fluorescence in the cells transfected 
with Sec24, Sec31, Rab1, and Rab5 was <1/10 of the GFP fluorescence of cells transfected with RFP and SEAP 
(Fig. 5B,C). In addition, when transfected with Sec24 and Sec31, the number of surviving cells with GFP fluores-
cence was <10% of those cells transfected with RFP (Fig. 5D). These results suggested that the expression limits 
Figure 2. Attachment of localization signals reduces the GFP expression limit. (A) Insert constructs used in 
the experiment. The MTS from human mitochondrial protein Cox8, the SS sequence from Trypanosoma brucei 
EP protein, and the ER retention signal KDEL were attached to GFP, as shown. (B–D) GFP expression levels 
of transfected HEK293 cells analyzed using flow cytometry. Histograms of GFP fluorescence (B,C), and the 
means and SD (error bar) are shown (D). (E) GFP expression levels of transfected cells analyzed using protein 
analysis. The total protein of each transfected cell was separated by SDS-PAGE. The red arrow indicates the size 
corresponding to GFP. (F,G) GFP expressed in transfected cells detected using western blotting with an anti-
GFP antibody. The band corresponding to the MTS-GFP precursor size is shown as Pre MTS-GFP. Measured 
intensities of the bands are shown as % of the band of the GFP experiment. The means and SDs from triplicated 
experiments are calculated and shown in (G). The uncropped image of (F) is attached as Fig. S3B. The flow 
cytometry histograms were created using the FlowJo software (https://www.flowjo.com/) ver. 8.8.7.
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of these proteins involved in vesicular transport are very low, and thus, overexpression of these proteins is toxic, 
as observed in yeast.
concentration of cells with higher plasmid copies using DHfR–MtX antagonism. So far, we 
estimated protein expression limits using the excessive efficiency of transfection. However, such transfected cell 
population contains cells with lower plasmid copy numbers than that required to achieve the protein expression 
limit. Therefore, the mean GFP expression level analyzed so far should be lower than the actual protein expression 
limit (Fig. 6A, left).
Therefore, we tried to concentrate those cells in which the target protein’s expression level was closer to the 
actual protein expression limit by using DHFR–MTX antagonism24. The mouse Dhfr gene under the control of the 
EF1-α promoter (EF1α-pro) was inserted into the plasmid pTOW-CMV-pro-D, as shown in Fig. 6B. Transfected 
cells with lower copy numbers of this plasmid were selectively eliminated by the addition of MTX, and the mean 
GFP expression level of the surviving cell population came closer to the protein expression limit (Fig. 6A, right). 
A pilot experiment suggested that treatment with 200 µM MTX eliminates most of the HEK293 cells after 24 h 
cultivation (data not shown). Therefore, we used 200 µM MTX for subsequent experiments.
Figure 3. Use of P2A-GFP for estimating the expression levels of N-terminal target proteins. (A) Concept 
of the experiment. Equimolar protein expression can be performed using the P2A sequence. Expression 
level of an N-terminal target protein (here RFP) thus can be indirectly estimated by the GFP expression level 
connected at the C-terminal after P2A peptide. (B) Microscopic analysis of transfected HEK293 cells. RFP and 
GFP fluorescence images were taken using a fluorescent microscope, and fluorescence intensities of cells were 
measured. We confirmed that each of RFP and GFP fluorescence was not leaked to the other fluorescent image 
(data not shown). (C) A scatter plot between RFP and GFP intensities. The Pearson correlation coefficient 
(r = 0.95) is shown. (D) Effect of noncleaved mutation in P2A peptide. A mutation in the P2A mutant (RFP-
P2A*-GFP) resulted in the formation of a fusion protein. (E) Detection of GFP in the cell extract of GFP, 
RFP-P2A-GFP, and RFP-P2A*-GFP expressing cells using western blotting with an anti-GFP antibody. The 
corresponding bands of GFP and noncleaved RFP-P2A-GFP are shown by arrowheads and indicated as 
“Cleaved” and “Noncleaved,” respectively. (F) Comparison of expression levels of RFP-P2A-GFP and RFP-
P2A*-GFP. RFP-P2A-GFP- or RFP-P2A*-GFP-expressing cells were analyzed using flow cytometry, and the 
GFP fluorescence mean was calculated.
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As shown in Fig. 6C, among cells transfected with the DHFR-GFP plasmid, 200 µM MTX treatment slightly 
depleted the portion of cells with lower GFP expression. The mean GFP fluorescence and the GFP protein level 
by western blotting slightly increased (Fig. 6D,E), and the former increase was statistically significant (p = 0.006, 
Student’s t-test). These results suggested that DHFR–MTX antagonism can be potentially used to increase the 
accuracy of estimation of the protein expression limit.
Discussion. While protein overexpression causes various cellular defects, the underlying mechanism is 
unknown. This mechanism is intrinsically associated with the level of overexpressed proteins3,4. Therefore, we 
need to know the protein level that causes cellular defects.
We previously developed the gTOW method to systematically estimate protein expression limits (e.g. expres-
sion levels that cause growth defects) in yeasts8–10. In the gTOW method, we can genetically estimate a protein’s 
expression limit using the characteristics of the multicopy plasmids used for gTOW; the intracellular plasmid 
copy number varies and can be increased using selection bias. Although estimation of the protein expression 
limit is not precise, because the method uses variance, because of its simplicity, the method can be used to analyze 
many different samples. In the gTOW method in yeasts, cells harboring higher plasmid copies are concentrated 
using the selection bias of marker genes. In contrast, concentrating these cells by selection from among cultured 
cells is not practical because their cell cycles are far longer compared to yeast cells. Therefore, we directly used the 
variance of high-efficient transfection. In the gTOW method, we used a target gene with its native promoter and 
terminator so that its expression limit could be estimated as a fold increase from the native level by measuring the 
plasmid copy number, and therefore, we can obtain the relative overexpression data for each target gene4. This 
is only applicable to organisms whose genome structures are compact: identification of a gene’s promoter region 
is relatively easy, and genes do not contain large introns. In contrast, in higher eukaryotes, such as mammals, 
Figure 4. Estimation of expression limits of secretory proteins SEAP and HSA. (A) Insert constructions used 
in the experiment. The SEAP signal sequence is shown as an amino acid sequence. SEAPΔSS represents SEAP 
without the signal sequence. (B,C) GFP expression levels of transfected HEK293 cells with the RFP, SEAP and 
HSA plasmids analyzed using flow cytometry. Histograms of GFP fluorescence (B), and the means and SD 
(error bar) are shown (C). (D) Microscopic analysis of transfected cells with RFP, SEAP and HSA plasmids. 
Contrasts of images were emphasized so that the GFP distribution in the cell is visible. (E,F) GFP expression 
levels of the cells with Flow cytometry of HEK293 cells with SEAP and SEAPΔSS plasmids analyzed using flow 
cytometry. Histograms of GFP fluorescence (E), and the means and SD (error bar) are shown (F). Mean GFP 
fluorescence of GFP-positive cells obtained by flow cytometry. The flow cytometry histograms were created 
using the FlowJo software (https://www.flowjo.com/) ver. 8.8.7.
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genome structures are much more complex and gene sizes are too large to clone into a plasmid. Therefore, system-
atic estimation of relative protein overexpression levels for many target genes is not practical.
In this study, we developed a method of estimating and comparing absolute overexpression levels of target 
proteins. We used self-cleaving P2A peptide so that protein synthesis levels of the marker protein GFP and the 
target protein were 1:1. We note that their final protein levels would not necessarily be the same when the stabili-
ties of these proteins are not the same (Fig. S1). In fact, while GFP is a stable protein harboring a half-life of many 
hours25,26, about 30% of synthesized proteins in human cells are degraded with a half-life of 1 hour27. Therefore, 
expression limits monitored by the GFP levels in our experiments using P2A peptide should be considered as the 
relative quantity reflecting the synthesis limits of target proteins rather than the limits of the final protein levels. 
Technically, the expression levels of target proteins can be directly assessed using western blotting with anti-P2A 
antibodies. Other possible way to directly assess the target protein level using GFP is to use fusion proteins. 
However, this might have the negative effects of fusing proteins with a 26 kDa GFP to either N- or C-terminal28. 
The cleaved GFP stayed in the cytoplasm, even if it connected with secreted proteins (Fig. 4D), and fusing GFP by 
introducing a mutation in P2A peptide negatively affected the expression limit (Fig. 3F).
In our previous work using yeast, we reported two potential mechanisms restricting expression limits of 
secreted proteins7; one is the ER stress where the secreted target protein is misfolded in the ER29, and the other is 
clogging where the target protein blocks the translocation machinery30. The normal GFP containing two cysteines 
aggregates through S-S bond and triggers the ER stress7. While moxGFP, a cysteine-free derivative of GFP, does 
not aggregate in the ER12 and thus does not trigger the ER stress, it has the same expression limit as GFP, probably 
because it clogs the translocation machinery7. In this study, we used moxGFP for all experiments to avoid arti-
ficial ER stress. The addition of secretion signal to moxGFP dramatically decreased its expression limit to about 
10% of that of moxGFP (Fig. 2), probably it triggers clogging in HEK293 cells as well. Interestingly, estimated 
expression limit of a secreted protein SEAP was about a half of that of a cytoplasmic protein RFP, and removal of 
the secretion signal from SEAP had a minor effect on its expression limit (Fig. 4). This suggests that SEAP might 
have a property to avoid the ER stress and clogging.
To overexpress target proteins, we used CMV-pro, which works as the strongest promoter in cultured 
cells19,20. In the experiment to estimate Sec24 and Sec31 expression limits, only a small part of the cells became 
GFP-positive (i.e., transfection was established) (Fig. 5), suggesting that CMV-pro is too strong to estimate the 
Figure 5. Estimation of expression limits of proteins involved in vesicular transport. (A) Insert constructs used 
in the experiment. (B) Flow cytometry of HEK293 cells transfected with each Sec24, Sec31, Rab1, and Rab5 
plasmid. (C) Mean GFP fluorescence of GFP-positive cells obtained by the flow cytometry in C. (D) Number of 
GFP-positive cells in the flow cytometry in (C). The flow cytometry histograms were created using the FlowJo 
software (https://www.flowjo.com/) ver. 8.8.7.
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expression limits of these proteins and that weaker or controllable promoters should be used to estimate very 
toxic proteins upon their overexpression.
In this study, we used the diversity in transient transfection to survey the expression limits of a target protein 
(Fig. 1). This method has its own merit that a wide range of expression levels can be surveyed with a single trans-
fection experiment, and thus can be suitable for analyzing various target proteins. Instead, it has a limitation that 
the measurement of the expression limit is inaccurate. For the precise measurement of the expression limit of a 
protein, the establishment of the stable cell lines with a controllable gene expression system like Tet-system31 or 
other inducible systems32 might be preferable.
We proposed a system of concentrating cells with higher plasmid copies using DHFR–MTX antagonism. 
However, the system showed only a minor improvement in the measurement (Fig. 6). While the DHFR–MTX 
system is established to create stable cell lines with high-copy integration33, it requires long-term selection and did 
not seem to work in our transient transfection system.
An interesting finding of this study was that GFP has an expression limit in HEK293 cells. Our estimate was 
~5% of total protein (Fig. 2), which was lower than that estimated in yeast (15% of total protein)7. However, cur-
rently, we cannot conclude whether the difference is due to the difference in cell species or experimental systems. 
As observed in yeast7, adding localization signals to GFP decreased its expression limit (Fig. 2). This finding 
supported the idea that the burden for localization determines the proteins’ expression limits in cultured cells as 
well. How does the overexpression of GFP, a gratuitous protein, affect cellular function? The cellular resource for 
protein production should have a limit, and extreme GFP overexpression overloads the resource. In microorgan-
isms, this situation is called the protein burden/cost and is observed as growth defects6. In this study, HEK293 
cells overexpressing GFP detached from the bottom of the culture dish, became spherical shaped, and eventually 
died (Fig. 1H,I). Similar cell death of other cell lines upon overexpression of GFP was also observed previously34. 
The next interesting question is whether there is an intrinsic sensing system of the overloading of protein pro-
duction. Such a system could work as a programmed suicide system upon viral infection or cancer development, 
where massive protein production is unrelated to cellular function.
Figure 6. Concentrating cells with higher plasmid copies using DHFR–MTX antagonism. (A,B) Experimental 
procedure. Cells are transfected with the plasmid shown in (B). After 24 h, MTX is added to the cells and the 
cells analyzed. Posttreatment, only cells with higher plasmid copies are selected. Virtual histograms in flow 
cytometry at each step are shown. See the main text for details. (C) Flow cytometry of cells transfected with the 
plasmid GFP-DHFR. The black-lined graph and the filled-green graph indicate cell counts treated with 0 and 
200 µM MTX, respectively. (D) Mean GFP intensity of GFP-positive cells obtained by flow cytometry in (C). 
(E) Mean GFP protein level of cells transfected with GFP-DHFR and treated with indicated MTX. GFP was 
detected by western blotting. The flow cytometry histograms were created using the FlowJo software (https://
www.flowjo.com/) ver. 8.8.7.
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In conclusion, we developed a method of estimating the protein expression limit in cultured cells using only 
one plasmid system. Because of its simplicity, this method can be applied to various different genes and con-
structs. It can also be combined to assess the effects of drugs, gene knockdown, and gene overexpression.
Materials and Methods
cell culture and transfection. We used HEK293 cells stocked in our laboratory. HEK293 cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM; Welgene) supplemented with 10% fetal bovine serum (FBS; 
Gibco). Next, the cells were seeded in 6-well culture plates to be confluent on the following day, with 1.5 mL medium 
in each well, and then incubated in a CO2 incubator overnight. Plasmid DNA and 1 mg/ml PEI “max” (24765–2; 
Polysciences, Inc.) in a 1:3 weight ratio were mixed with 500 µL of DMEM, and the mixture was incubated for 
20 min at room temperature. Finally, the mixture was dropped into each well and incubated in the CO2 incubator.
plasmids. The plasmids we used in this study are listed in Supplementary Table S1, and their sequences are 
available upon request. The plasmids were constructed by the homologous recombination activity of yeast cells. 
CMV-pro, moxGFP, and the SV40 polyA signal were obtained from the plasmid moxGFP (plasmid #68070; 
Addgene). The MTS was from human mitochondrial protein Cox835, and the SS was from Trypanosoma brucei 
EP protein36,37.
flow cytometry. The transfection efficiency, GFP expression level, and number of dead cells were assessed 
by flow cytometry using the Cell Lab Quanta flow cytometer (Beckman Coulter). HEK293 cells were centrifuged 
at 2300 g for 2 min and resuspended in 500 µL of phosphate-buffered saline (PBS, 14249–95; Nacalai tesque). A 
maximum of 20,000 events (cells) were analyzed per sample. GFP fluorescence was detected using the FL1 chan-
nel. The mean GFP fluorescence (AU) of cells was calculated from the GFP fluorescence of GFP-positive cells 
(FL1 > 100.2), and the mean and SD of AUs from three biological experiments were calculated. We note that the 
AUs are only comparable within each experiment but not among different experiments, because the sensitivities 
of the fluorescence detection were altered among experiments.
Microscopic observation. For cellular images in Fig. 1, cultured cells were directly observed under an 
Olympus 20-fold objective lens microscope (Olympus). Fluorescence images were observed using the GFP filter 
cube. Cellar images used in Figs. 2 and 3 were obtained using the DMI6000 B microscope and Leica Application 
suite X (Leica Microsystems). The mean GFP and RFP fluorescence intensities of each cell obtained by GFP and 
RFP filter cubes were calculated using a CellProfiler software (ver. 2.2.0, http://cellprofiler.org) pipeline; the pipe-
line is available upon request.
MTX treatment for DHFR-expressing HEK293 cells. HEK293 cells were transfected with the plasmid 
harboring DHFR and cultured in a CO2 incubator for 24 h. The medium was removed, the cells were washed with 
1 mL of PBS, and the medium and MTX (139–13571; FujiFilm Wako Pure Chemical) were added to the wells. 
The cells were again cultured in the CO2 incubator for 48 h. Finally, the cells were analyzed using flow cytometry 
and western blotting.
protein analysis. After removal of the medium, the cells were washed with 1 mL of PBS. The cells were 
treated with 250 µL of trypsin solution (32778–05; Nacalai tesque), and suspended with 500 µL of PBS. The cells 
were collected by centrifugation at 2,300 g for 2 min. After removal of the buffer, the cells were suspended with 
500 µL of 4 x NuPAGE LDS sample buffer (NP0007; Thermo Fisher Scientific) and incubated at 70 °C for 10 min. 
The solution was centrifuged at 15, 000 rpm for 5 min. The supernatant then was diluted twice with H2O, and 
used for further analysis as the total protein solution. This treatment completely terminates the fluorescence 
of GFP (Fig. S2). For visualization of the total protein, the total protein solution was mixed with the Ezlabel 
FluoroNeo fluorescent dye (WSE-7010; ATTO) at a final concentration 1 x, and incubated at 95 °C for 3 min. 
The labeled protein was separated using the NuPAGE 4–12% Bis-Tris Gel (NP0322; Thermo Fisher Scientific). 
The proteins were detected using the LAS-4000 image analyzer (GE Healthcare) in the SYBR-green fluorescence 
detection mode, and the intensities were measured using the ImageQuant TL software (GE Healthcare). To detect 
GFP by western blotting, an anti-GFP antibody (11814460001; Roche), a peroxidase-conjugated secondary anti-
body (414151 F; Nichirei Biosciences), and a chemiluminescence reagent (34095; Thermo Fisher Scientific) were 
used. A chemiluminescence image was acquired using LAS4000 in the chemiluminescence detection mode, and 
intensities were measured using the ImageQuant TL software ver. 8.1 (GE Healthcare, https://www.gelifesciences.
com/). Calculation of the GFP level over the total protein (%), and the relative expression level of GFP (AU) were 
performed as shown in Fig. S3. We note that the AUs are only comparable within each experiment but not among 
different experiments, because we did not use any standard in the western blotting.
Statistical analysis. Data were analyzed using the FlowJo software (https://www.flowjo.com/) ver. 8.8.7. The 
mean and SD of the mean GFP intensity of GFP-positive cells were calculated from three independent biological 
experiments. Two-tailed Student’s t-test was used for statistical tests.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
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